Rosati RA: The nature and treatment selection on coronary artery disease: Experience with medical and surgical treatment of chronic disease. Circulation 49: 606, 1974 The Relationship A minimum of six days was allowed for recovery from the operative procedure. The morning of the study, the snare and catheters were brought from the subcutaneous pouch to the surface while the animal was under subcutaneous lidocaine infiltration anesthesia. The animals were loosely restrained and studied while awake and resting quietly on their right sides. Hemodynamic measurements were obtained in six of the seven animals subjected to proximal circumflex occlusion. The aortic and left atrial pressure catheters were attached to pressure transducers (Statham model P23Db) the zero level of which was set at midchest level. A lead III electrocardiogram and phasic and mean pressures were recorded on a direct-writing oscillograph (Hewlett-Packard model 8800) and eight-channel magnetic tape recorder (Hewlett-Packard model 3917-A). After all the recording instruments had been connected, a 30 to 35 min period was allowed for the animals to adjust to the quiet laboratory conditions. Acute myocardial infarction was then produced by complete closure of the snare over a 15 min interval. Coronary occlusion was verified by ST-segment elevation and an increase in heart rate and left atrial pressure as the occluder was closed. Morphine sulfate (10 mg) was administered intravenously in divided 2-3 mg dosages during the initial 30 min postocclusion to minimize any discomfort resulting from the occlusion. Lidocaine (2 mg/kg) was administered as a bolus injection at 15 min intervals for the first hour. No analgesics or antiarrhythmic agents were administered after the initial one hour of occlusion.
range of infarct size, an adjustable snare-type polyethylene occluder was positioned on the large circumflex coronary artery, either distal or proximal to the first large marginal branch. Chronic indwelling heparin-filled catheters were placed in the left atrium via the appendage and in the central aorta via the internal thoracic artery for monitoring pressure. The catheters and snare were tunnelled to a subcutaneous pouch at the base of the neck.
A minimum of six days was allowed for recovery from the operative procedure. The morning of the study, the snare and catheters were brought from the subcutaneous pouch to the surface while the animal was under subcutaneous lidocaine infiltration anesthesia. The animals were loosely restrained and studied while awake and resting quietly on their right sides. Hemodynamic measurements were obtained in six of the seven animals subjected to proximal circumflex occlusion. The aortic and left atrial pressure catheters were attached to pressure transducers (Statham model P23Db) the zero level of which was set at midchest level. A lead III electrocardiogram and phasic and mean pressures were recorded on a direct-writing oscillograph (Hewlett-Packard model 8800) and eight-channel magnetic tape recorder (Hewlett-Packard model 3917-A). After all the recording instruments had been connected, a 30 to 35 min period was allowed for the animals to adjust to the quiet laboratory conditions. Acute myocardial infarction was then produced by complete closure of the snare over a 15 min interval. Coronary occlusion was verified by ST-segment elevation and an increase in heart rate and left atrial pressure as the occluder was closed. Morphine sulfate (10 mg) was administered intravenously in divided 2-3 mg dosages during the initial 30 min postocclusion to minimize any discomfort resulting from the occlusion. Lidocaine (2 mg/kg) was administered as a bolus injection at 15 min intervals for the first hour. No analgesics or antiarrhythmic agents were administered after the initial one hour of occlusion.
Venous blood samples were obtained at hourly intervals during the first 12 hours, at three hour intervals for the next 24 hours, six to 12 hour intervals for 48 hours, and daily thereafter. The animals were sacrificed 5-6 days following occlusion, an interval that allowed sufficient time for the infarcted and noninfarcted myocardium to become clearly delineated by routine histologic techniques. At postmortem examination, the heart was removed and the left ventricle was sectioned into eight transverse rings from base to apex. Transmural tissue blocks weighing one to three grams each were obtained from the entire ischemic region of each ring. Each sample was weighed and prepared for histologic section. A minimum of two-step sections were taken through each small tissue block. The percentage of histologic myocardial infarction in each sample was determined using grid markers which divided each section into equal 12.5 to 25% regions. The total infarct was determined from the sum of the weight of infarction in each individual sample. Infarcted myocardium at this point was sharply delineated from intact myocardium and was characterized by complete or partial cellular dissolution, inflammatory cell infiltrates, and loss of normal cellular architecture. Eleven of the 14 animals had duplicate histologic estimates by two different observers.
The following enzyme determinations were performed on each blood sample: CPK by the modified Rosalki method,'
lactate dehydrogenase (LDH),6 isoenzyme fractionation of LDH and CPK by previously described methods. 7 Creatine phosphokinase levels were determined using Spin-Chem reagent (Smith-Kline Instruments) on the Centrifichem programmable analyzer (Union Carbide Corp.) which has a tested kinetic precision within 3 millioptical density units. CPK and LDH determinations were performed at 37°C in all samples. CPK was also determined at 30°C in seven dogs.
Infarct Size Estimation from Serial Values of CPK and its Isoenzymes
Estimates of the extent of infarction were determined using the basic formula described by Shell et al. 1 Three of the animals (8, 11, 12) (5007) 530 (1016) 420 (989) 477 (2499) 590 (3307) 635 (2581) 420 (568) 830 (5441) 570 (1146) 483 (1292) 585 (3742) 655 (3333) 690 (2659) 555 (1588) 1010 (7627) 600 (1302) 565 (1226) 603 (3594) 725 (3207) 755 (2901) 600 (2000) 1220 (6504) 615 (1510) 633 (1437) 663 (3489) 765 (3079) 795 (2953) 675 (2391) 1415 (7172) 655 (1966) 666 (1305) 720 (3632) 935 (2734) 980 (3061) 730 (2805) 1490 (5918) 718 (1953) 722 (1265) 795 (3968) 1135 (2538) 1190 (2919) 780 (2831) 1715 (5381) 775 (2279) 925 (923) 960 (4036) 1250 (2352) 1295 (3129) 840 (2913) 1875 (3895) 970 (2279) 1097 (778) 1136 (3841) 1305 (2333) 1400 (2553) 1005 (2784) 2200 (1780) 1165 (1523) 1292 (475) 1339 (3229) 1585 (2039) 1520 (2211) 1205 (2033) 2845 (1494) 1300 (1198) 1438 (538) 1511 (2414) 1730 (1595) 1685 ( r' = 0.99, N = 7. All parameters, other than CPKD and background level, were the same for estimates at either temperature. Since CPK activity is significantly influenced by assay temperature, failure to correct the values for CPKD and background levels produced extensive alteration in the magnitude of the infarct estimate.
Relationship of Different Enzymatic Estimation Methods to Anatomic Infarct Size
The serial CPK and isoenzyme values determined at 37°C and corresponding time, in minutes, following coronary occlusion in all animals are presented in tables 3 and 4, respectively. In both tables, the bracketed values represent serum samples containing myocardial LDH isoenzyme patterns.
The data points, time span, and squared correlation coefficient (r 2) of the individualized Kd for total CPK, CPK-MM, and CPK-MB are presented in table 5 . These values were used in the calculations of infarct size by the Norris and Roberts methods. The limitations of selecting an individualized Kd are most apparent in the CPK-MB group. Three animals (4, 9, and 10) had relatively low r2 values, while dogs 7 and 13 had no CPK-MB at any time. Noninfarcted myocardium and duodenum were obtained from dog 13 at postmortem examination. Although CPK-MB was identified in the duodenal extract, CPK-MB was not present in myocardium. Tissue studies were not obtained in dog 7. However, despite the absence of CPK-MB in postocclusion serum samples, these two dogs sustained histologic infarcts of 9.3 and 26.3 grams, respectively.
The enzyme estimates of infarct size (g-equivalents) obtained from serial CPK and CPK isoenzyme data by the Shell, Norris, and Roberts methods and histologic measurements of infarct size are presented in tables 6 and 7. Table 6 summarizes body weights and results obtained using the entire enzyme curve while table 7 presents the estimates from CPK and isoenzyme data restricted to the LDH identified cardiac zones. Table 8 summarizes, for the total group of animals, the results of the regression analyses between enzyme estimates (using the Shell, Norris, and Roberts methods for calculation) and histologic measurements of infarction. Estimates were calculated from the following serial measurements: total CPK, CPK-MM, and CPK-MB for the complete curves, as well as for that portion of the curve where LDH isoenzymes indicated a cardiac origin. Estimates from serial CPK-BB measurements were performed by the Shell method only. Since CPK-MB was absent in two dogs, the regression formula and correlations for CPK-MB are given for N = 12 (all with CPK-MB) as well as N = 14.
The result of the regression analyses using the Shell method and the total group of animals indicates that there was a very poor correlation between enzyme estimates and histologic measurements of infarct size. The correlations were not improved by using isoenzyme analyses, restriction of the data to the LDH portion of the curve, or the use of the modified parameters recommended by Norris and Roberts. Several additional procedures using total CPK and the Shell method were employed in an attempt to improve the correlation. Three animals required defibrillation with DC countershock (8, 1 1, and 12) and two animals had high CPK values prior to occlusion (1 and 4). Exclusion of defibrillated animals, or those with high control CPK levels, or both of these groups did not improve the correlation (r2 < 0.08). Significant amounts of the noncardiac isoenzyme, CPK-BB, were present in certain dogs. This would produce a non- figure 2 . The estimates were derived from the serial total CPK (s) and CPK-MM (0). The proximity of total CPK to CPK-MM estimates is an index of the extent of the noncardiac enzyme contribution to the total CPK estimate. The animals segregate into two groups according to histologic infarct size. There are nine animals with infarct size of less than 13 grams and five with infarct size greater than 20 grams. The mean infarct size for these two groups was 6.2 and 24.9 grams, respectively. From figure 2 it appeared that the poor correlation obtained from analysis of the total group may have resulted from inclusion of animals with larger infarcts. Regression analyses between enzyme estimate and histologic measurements in the latter group demonstrated essentially no relationship, r2 values were < 0.12.
To determine whether animals with larger infarcts contributed to the poor correlation, regression analyses were performed using animals with histologic infarct size of less than 13 grams (dogs 1-9). The results of the regression analyses are shown in table 9. Using the Shell method, the squared correlation coefficients in this group as compared to the total group increased as follows: CPK (r2 = 0.42), CPK-MM (r2 = 0.67), and CPK-MB (r2 = 0.37). When the animal without CPK-MB (7) was excluded, r2 was 0.70.
Estimates derived from serial CPK-BB measurements had no correlation with histologic infarct size (r2 = 0.05). Restriction of the analysis to the points on the curve where LDH isoenzymes indicated a cardiac source further improved the correlation as follows: CPK (r2 = 0.65), CPK-MM (r2 = 0.71), CPK-MB (r2 = 0.53, N = 9, and = 0.82, N = 8).
In the group with infarct size less than 13 grams the correlation between enzyme estimates and histology could also be improved by excluding the animals which were defibrillated (8) and which had high control enzyme levels (1, 4). The coefficients were as follows: CPK (r2 = 0.61), CPK-MM (r2 = 0.72), and CPK-MB (r2 = 0.39, N = 6, or r' = 0.87, N = 5). Therefore, limiting the analysis to animals with histologic infarcts less than 13 grams resulted in significant correlation between enzyme estimates by the Shell method and the histologic extent of infarction. Although a good correlation was achieved, the enzyme estimates markedly overestimated histologic infarct size. CPK-MB produced the best correlation but the most extensive overestimation. When the entire group was analyzed, it was not possible to differentiate between small and large infarcts by the enzyme estimates ( fig. 2, tables 6 (table 9 ). In the total group, there was no correlation in any enzyme category and attempts to improve the correlation failed. Elimination of the defibrillated animals, dogs with high control enzyme levels, or both of these groups yielded no improvement. Exclusion of those animals with CPK-BB contributing 5% or greater to the total CPK estimate did not change the correlation.
As compared to the Shell method, analysis of data from animals 1-9 (smaller infarcts) using the Norris and Roberts methods reduced the correlation with total CPK (r2 = 0.12) and CPK-MM (r2 = 0.11) but increased the correlation with CPK-MB when the animal without CPK-MB (7) was excluded (r2 = 0.82). The correlation with CPK-MB was further enhanced by restricting the data to the LDH cardiac zone (r2 = 0.91) or by excluding the defibrillated animal and the two with high control CPK levels (r 2 = 0.96). The mean individualized Kd (± SD) for those nine animals was -0.0014 ± 0.0005, -0.0014 ± 0.0007, and -0.0019 ± 0.0006 minm' (N = 8) for CPK, CPK-MM, and CPK-MB, respectively. Individualization of the K appeared responsi- 1-9. individual CPK level at the time of occlusion, and the average CPK level in all samples for each animal prior to the appearance of LDH cardiac isoenzyme patterns.
The first three categories resulted in infarct estimates which had essentially identical correlation with histologic infarction, identical slopes for regression lines, but progressively lowered Y-intercepts. This was consistent with an additive effect on enzyme estimates as background level was reduced from 130 to 0 I.U./L. When background level was individualized, there was little effect on correlation or regression lines. Discussion
Shell et al.' proposed a method for estimating the extent of myocardial infarction in dogs based on serial measurements of serum CPK at 30°C. These studies were performed on chronically prepared awake dogs subjected to occlusion of branches of the left anterior descending coronary artery (LAD). These investigators equated the extent of infarction to myocardial CPK depletion. They reported a close correlation between enzyme estimates and CPK depletion, r = 0.95 (r2 = 0.90). When the enzyme estimates were recalculated from the serial enzyme measurements, the corrected correlation coefficient was r = 0.82 (r2 = 0.67).2 This method for estimating the extent of infarction was then applied to studies of patients with myocardial infarcts. The results were felt to correlate well with the clinical assessment of the severity of infarction.' Norris et 4 were used to estimate the extent of myocardial infarction. The experimental design of the present study differed in certain respects from the studies performed by Shell. Shell et al.' produced infarction by occluding branches of the left anterior descending coronary artery (LAD) and the extent of myocardial infarction was determined by myocardial CPK depletion at 24 hours. In the present study, the occluder was placed on the circumflex coronary artery either proximal or distal to the first marginal branch. This produced a range of histologic infarct size of 0.1-26.6 grams determined 5-6 days after occlusion. In previous studies involving occlusion of branches of the LAD, infarct estimates from myocardial CPK depletion ranged from 6-45 grams. Estimates from serial CPK measurements extended from 8-63 gram-equivalents." 2 Thus, in the present study, the range of initial ischemia and the technique for direct assessment of the extent of myocardial infarction represent differences from previous studies and may account for certain differences in the results.
The relationship between histologic measurements and all three methods for enzyme estimation was evaluated by the least squares regression analysis. Several procedures were used in an attempt to determine the optimum relationship. First, estimates were calculated from the complete curves using total CPK as well as the isoenzymes, CPK-MB, CPK-MM, and CPK-BB. Second, in addition to using the complete CPK curve, enzyme estimates were calculated from only that portion of the CPK curves where simultaneous LDH isoenzymes indicated a cardiac zone. Third, animals in which the noncardiac isoenzyme, CPK-BB, contributed greater than 5% to the total estimate, animals which required DC defibrillation or which had high initial levels of CPK, were excluded from the analysis. Finally, the total group was separated into a group with infarct size 13 grams or less (small infarcts) and a group in which infarct size was greater than 20 grams (large infarcts). The above analyses were applied to each of the latter subgroups. The data indicate that the major factor responsible for the poor correlation between estimates and histologic measurements of infarction was the inclusion of animals with large infarcts. The loss of correlation produced by the larger infarcts resulted from relatively less total enzyme release in the larger as compared to the smaller infarcts. Hemodynamic measurements were obtained in animals subjected to proximal circumflex occlusion, and thus, included animals with an infarct range of 5.9-26.6 grams. Hemodynamic measurements in these animals demonstrated a slight reduction in arterial pressure and an increase in left atrial pressure. Noncardiac isoenzyme, CPK-BB, contributed minimally to the total CPK in this group, indicating little hemodynamic compromise of noncardiac tissue.
Blood flow to the infarcted region may be an important variable which affects the amount of enzyme observed peripherally following myocardial infarction. In previous studies from our laboratory,'0 blood flow to the region subjected to ischemia increased an average of 112% in the 24 hours following occlusion. The increase in collateral flow was variable. In animals with comparable infarct size, flow increased 50 to 250%. It is possible that changes in flow may result in variable release of enzyme from the infarcted myocardium such that the value for KR might be influenced. The infarcted myocardium at the periphery may be better perfused than that in the center. It is possible that small regions of infarction which subsequently are well perfused with collateral flow might generate a CPK-time curve equivalent to the curve associated with larger infarcts which receive less subsequent collateral flow.
In the present study, estimation of myocardial infarction using the original Shell technique resulted in a general overestimation of histologic infarction and did not distinguish large from small infarcts. The recommended changes by Norris and Roberts reduced the overestimation but also did not distinguish large from small infarcts. The poor correlation was not improved by using isoenzyme data and did not result from extracardiac release of enzymes.
The mathematical model, therefore, is most useful in animals with small histologic infarcts where parameter values are not individualized. The effect of changing the value for a parameter affects the magnitude of the estimate but fails to improve the correlation between enzymatic estimation and histologic measurement of myocardial infarct size.
while in nine shock cases it averaged 3.98 L/min by dye-dilution or Fick and 3.75 L/min by CO2 rebreathing (r = 0.94). In five heart failure cases with mitral insufficiency, which may distort dye curves, correlation between standard and rebreathing methods was r = 0.09, but in 16 cases without mitral regurgitation, r = 0.89. Acute interventions in ten patients increased dye-dilution cardiac output by 0.92 L/min and rebreathing outputs by 0.60 L/min (r = 0.87). The data suggest that the CO2 rebreathing cardiac output method may be useful in the CCU-MICU setting.
method. Despite a multitude of theoretical problems with this method, several investigators have demonstrated the validity of the CO2 rebreathing method compared to standard invasive methods in normals at supine rest, as well as during exercise.10"12 We have recently reported close correlation between the CO2 rebreathing and dye-dilution methods for measuring cardiac output in patients with uncomplicated hypertension and in a few patients with congestive heart failure.'4 We found the method to be highly reproducible and to accurately reflect changes in cardiac output.
In recent years hemodynamic monitoring of seriously ill patients has become more commonplace.1617 The techniques of hemodynamic monitoring are usually invasive and therefore may be technically difficult as well as uncomfortable and risky for the patient. The CO2 rebreathing method for measuring cardiac output is quickly and easily applied, virtually without risk, and totally noninvasive. The present study was therefore carried out to compare the CO2 rebreathing method to standard invasive cardiac output techniques in critically ill patients to see if the noninvasive method might be of value in obtaining information useful for the management of such patients.
Methods
Cardiac output by the CO2 rebreathing method is calculated from the Fick equation, Q = VC02 Cvo2 -Caco2 where Q = cardiac output (L/min), VC02 = CO2 production (ml/min), CV02 = CO2 content of mixed venous blood
